-
McKesson, Kinder Morgan And 2 Other Stocks Insiders Are Selling
Tuesday, August 8, 2023 - 8:20am | 641The Nasdaq 100 closed higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not...
-
Wayfair To Rally Over 32%? Here Are 10 Other Analyst Forecasts For Monday
Monday, August 7, 2023 - 7:52am | 556Needham raised the price target for MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) from $65 to $84. Needham analyst Quinn Bolton maintained a Buy rating. MACOM Technology shares rose 0.1% to $170.70 in pre-market trading. RBC Capital cut Sage Therapeutics, Inc. (NASDAQ: SAGE) price...
-
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Thursday, August 3, 2023 - 8:06am | 539Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in pre-market trading. Canaccord Genuity cut PayPal Holdings, Inc. (NASDAQ: PYPL) price target from $...
-
Fear & Greed Index Moves To 'Greed' Zone After S&P 500 Settles Lower
Wednesday, August 2, 2023 - 3:47am | 352U.S. stocks closed mixed on Tuesday, as investors digested recent earnings reports and a fresh batch of economic data. Merck & Co Inc (NYSE: MRK) posted a narrower-than-expected quarterly loss, while sales topped estimates. Pfizer Inc (NYSE: PFE) reported a second-quarter adjusted EPS of $0.67...
-
Masimo, Medical Device Maker Drops On Q2 Guidance, Opportunity?
Wednesday, July 26, 2023 - 11:53am | 693Shares of health monitoring technology maker Masimo Corporation (NASDAQ: MASI) dropped 24% to $114.30 last week due to a second-quarter performance warning. They are at their lowest level since January 2019 — but according to Wall Street, could have healthy gains ahead. The Irvine,...
-
Verrica's Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA Approval
Tuesday, July 25, 2023 - 1:03pm | 405Monday, the FDA approved Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) Ycanth (cantharidin) topical solution for molluscum contagiosum (molluscum) in adult and pediatric patients two years of age and older. Needham upgraded the stock to Buy from Hold with a price target...
-
Cue Health's Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
Monday, July 24, 2023 - 8:04am | 1010Last month, the Food and Drug Administration (FDA) granted a landmark De Novo authorization for Cue Health’s (NASDAQ: HLTH) at-home COVID-19 test that delivers lab-quality results within 20 minutes. The move makes Cue Health the first company to receive De Novo authorization for an at-home...
-
Cue Health's Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
Monday, July 24, 2023 - 8:03am | 1010Last month, the Food and Drug Administration (FDA) granted a landmark De Novo authorization for Cue Health’s (NASDAQ: HLTH) at-home COVID-19 test that delivers lab-quality results within 20 minutes. The move makes Cue Health the first company to receive De Novo authorization for an at-home...
-
BofA Analyst Cuts Price Target for AMD, Re-rates Semiconductor Companies, Expects Long-Term Stock Momentum For Sector
Tuesday, July 18, 2023 - 4:00pm | 787BofA analyst Vivek Arya sees Q2 for U.S. semiconductor companies in line and modestly below Q3 on lukewarm macro, but CY24 EPS recovery could sustain longer-term stock momentum. The analyst upgraded Camtek Ltd (NASDAQ: CAMT) to Buy and raised the price target to $50 from $...
-
Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates
Tuesday, July 18, 2023 - 1:56pm | 525Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the price target to $136 from $207. The company recently reported Q2 2023 preliminary results and revised the 2023 outlook yesterday. MASI expects revenues of $453...
-
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Tuesday, July 18, 2023 - 1:00pm | 1354Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. The Singing Machine Company, Inc. (NASDAQ: MICS) shares surged 32% to $2.10 after the company announced it launched a new party accessory product line...
-
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
Tuesday, July 18, 2023 - 8:12am | 803Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares gained 41.8% to $0.3729 in...
-
Microsoft To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday
Tuesday, July 18, 2023 - 7:37am | 550B of A Securities boosted the price target for Camtek Ltd. (NASDAQ: CAMT) from $30 to $50. B of A Securities analyst Vivek Arya upgraded the stock from Neutral to Buy. Camtek shares rose 1.8% to $44.02 in pre-market trading. Loop Capital cut Leslie's, Inc. (NASDAQ: LESL) price target from...
-
Why Masimo Shares Are Dipping Today
Tuesday, July 18, 2023 - 5:41am | 534Masimo Corp (NASDAQ: MASI) shares are trading lower after the company reported Q2 2023 preliminary results and revised 2023 outlook yesterday. Q2 2023: The company expects revenues of $453 million- $457 million range (consensus: $553.23 million). The healthcare revenue is expected to be $...
-
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Monday, July 17, 2023 - 1:14pm | 1789Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline. Acumen Pharmaceuticals, Inc. (NASDAQ:...